Mannatech (MTEX) AI Stock Analysis

• Market Cap: $16.44M
• Dividend Yield: N/A
• Average Volume (3M): 20.34K
• Price to Earnings (P/E): ―
• Beta (1Y): 0.44
• Revenue Growth: -9.17%
• EPS Growth: -4.64%
• Country: US
• Employees: 189
• Sector: Consumer Defensive
• Sector Strength: 42
• Industry: Household & Personal Products
• EPS (TTM): 1.01
• Shares Outstanding: 1,900,930
• 10 Day Avg. Volume: 5,058
• 30 Day Avg. Volume: 20,342
• PEG Ratio: -0.05
• Price to Book (P/B): 2.94
• Price to Sales (P/S): 0.21
• P/FCF Ratio: 12.89
• Enterprise Value/Market Cap: 1.17
• Enterprise Value/Revenue: 0.17
• Enterprise Value/Gross Profit: 0.23
• Enterprise Value/Ebitda: 10.98
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 50 Neutral
• Price Target: $9.50 ▲(9.83% Upside)

Mannatech's overall stock score reflects significant financial challenges, including declining revenues and negative profitability. Technical analysis provides some positive signals with short-term upward trends, but valuation concerns due to a negative P/E ratio weigh heavily on the score. The absence of earnings call insights and corporate events limits the analysis to financial and technical factors.

Positive Factors

Business Model Strength

Mannatech's direct selling model fosters a scalable sales force, enhancing market penetration and driving consistent product sales through a network of motivated associates.

Product Innovation

Mannatech's focus on glyconutritional technology positions it as a leader in health innovation, potentially attracting health-conscious consumers and differentiating it from competitors.

Gross Profit Margin

A strong gross profit margin indicates effective cost management and pricing power, supporting long-term profitability even amidst revenue challenges.

Negative Factors

Declining Revenue

Declining revenue growth suggests market share loss or reduced demand, potentially impacting long-term financial health and strategic positioning.

Negative Profitability

Negative profitability reflects operational inefficiencies and potential cash flow issues, which could hinder reinvestment and growth opportunities.

Negative Operating Cash Flow

Negative operating cash flow indicates potential liquidity issues, limiting the company's ability to fund operations and invest in growth without external financing.

Mannatech Business Overview & Revenue Model

Company Description

Mannatech, Incorporated operates as a health and wellness company worldwide. It develops, markets, and sells nutritional supplements; topical and skin care, and anti-aging products; and weight-management products. The company primarily sells its products directly, as well as through e-commerce and network marketing channels. Mannatech, Incorporated was founded in 1993 and is headquartered in Flower Mound, Texas.

How the Company Makes Money

Mannatech generates revenue primarily through the direct sales of its products by a network of independent distributors. The company utilizes a multi-level marketing (MLM) structure, where distributors earn commissions based on their sales and the sales made by their recruited downline. Key revenue streams include the sale of dietary supplements, skincare products, and personal care items. Additionally, Mannatech may engage in partnerships with various health and wellness organizations to enhance product visibility and reach. The company also benefits from its focus on product innovation and customer loyalty programs, which help sustain ongoing sales and repeat business.

Mannatech Financial Statement Overview

Summary

Mannatech's financial performance is challenged by declining revenues and negative profitability. The income statement shows a negative net profit margin and operational inefficiencies. The balance sheet indicates manageable leverage but poor return on equity. Cash flow analysis reveals negative operating cash flow, although there is some efficiency in converting income to cash.

Income Statement

Mannatech's income statement shows a declining revenue trend with a negative revenue growth rate of -2.27% in the TTM period. The gross profit margin remains relatively strong at 75.69%, but the net profit margin is negative at -1.50%, indicating profitability challenges. The EBIT and EBITDA margins are also low, suggesting operational inefficiencies.

Balance Sheet

The balance sheet reveals a moderate debt-to-equity ratio of 0.87, indicating manageable leverage. However, the return on equity is negative at -22.75%, reflecting poor profitability relative to shareholder equity. The equity ratio is not provided, but the overall financial stability appears to be under pressure due to declining equity.

Cash Flow

Cash flow analysis shows a concerning trend with negative operating cash flow and free cash flow in the TTM period. Although there is a positive free cash flow growth rate of 28.81%, the operating cash flow to net income ratio is negative, highlighting cash flow challenges. The free cash flow to net income ratio is relatively high at 79.43%, indicating some efficiency in converting income to cash.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	110.41M	117.87M	131.96M	137.21M	159.76M	151.41M
Gross Profit	82.95M	91.46M	102.86M	102.52M	125.61M	113.91M
EBITDA	1.76M	5.55M	498.00K	3.02M	10.61M	9.66M
Net Income	-1.66M	2.49M	-2.24M	-4.49M	9.84M	6.26M
Balance Sheet
Total Assets	33.92M	36.06M	41.21M	49.13M	59.63M	65.33M
Cash, Cash Equivalents and Short-Term Investments	7.69M	11.40M	7.73M	13.78M	24.18M	22.21M
Total Debt	8.10M	6.69M	5.71M	6.21M	1.83M	2.83M
Total Liabilities	26.97M	27.44M	30.72M	34.95M	35.21M	39.36M
Stockholders Equity	6.95M	8.61M	10.48M	14.18M	24.41M	25.97M
Cash Flow
Free Cash Flow	-3.97M	1.96M	-3.12M	-3.66M	10.12M	5.08M
Operating Cash Flow	-2.89M	2.26M	-2.37M	-2.60M	10.77M	6.03M
Investing Cash Flow	-1.06M	-285.00K	-747.00K	-1.06M	-650.00K	-947.00K
Financing Cash Flow	-1.22M	1.96M	-1.90M	-4.33M	-9.29M	-9.92M

Mannatech Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 8.65
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Positive
• RSI: Neutral
• STOCH: Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For MTEX, the sentiment is Negative. The current price of 8.65 is below the 20-day moving average (MA) of 9.40, below the 50-day MA of 9.27, and below the 200-day MA of 9.35, indicating a bearish trend. The MACD of -0.09 indicates Positive momentum. The RSI at 39.23 is Neutral, neither overbought nor oversold. The STOCH value of 7.07 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for MTEX.

Mannatech Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
EWCZ	64 Neutral	$220.70M	15.57	15.38%	―	-5.47%	13.42%
Sector *	62 Neutral	$20.33B	14.63	-3.31%	3.23%	1.93%	-12.26%
NUS	61 Neutral	$517.24M	4.88	14.55%	2.26%	-12.10%	―
EPC	58 Neutral	$808.48M	32.61	1.62%	3.45%	-1.34%	-73.59%
SKIN	51 Neutral	$178.50M	-6.33	-18.73%	―	-13.14%	57.98%
MTEX	50 Neutral	$16.44M	-10.05	-19.54%	―	-9.17%	-4.64%
TKLF	48 Neutral	$10.56M	1.69	16.79%	―	7.75%	-21.61%

Mannatech Corporate Events

Mannatech Extends Loan Repayment to March 2027

On September 9, 2025, Mannatech, Incorporated entered into Loan Extension Agreements with three board members and stockholders, extending the repayment of $3.6 million in loans to March 31, 2027. This extension allows Mannatech additional time to use the funds for general working capital needs, with the option to prepay without penalty.